13FPulse
TN

TNGX TANGO THERAPEUTICS INC

2026Q2 · CUSIP 87583X109 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
245
Institutions that reported holding it to the SEC
Net increase in holders
+52
Last quarter 193 → now 245
How unusual is that
Top 5%
Stronger buying than 95% of US stocks
What the filings say, in one paragraph

245 funds held TNGX at the end of 2026Q2, up 52 from the quarter before. That is stronger buying than 95.0% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $54M(YoY +121.5%), return on equity is -12.1%. TNGX has had 8 buying rushes in its history, and the price moved +40.2% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q4: holders=58 2022Q1: holders=72 2022Q2: holders=77 2022Q3: holders=87 2022Q4: holders=81 2023Q1: holders=90 2023Q2: holders=88 2023Q3: holders=99 2023Q4: holders=121 2024Q1: holders=126 2024Q2: holders=120 2024Q3: holders=122 2024Q4: holders=137 2025Q1: holders=121 2025Q2: holders=116 2025Q3: holders=142 2025Q4: holders=170 2026Q1: holders=193 2026Q2: holders=245 -52 -26 +0 +26 +52 52155258 21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5%
2026Q1 Top 20% +45.1%
2025Q4 Top 20% +60.3% +70.7%
2025Q3 Top 20% +11.7% +54.8%
2023Q3 Top 20% +28.4% +56.2%
2023Q1 Top 20% -14.4% +93.5%
2022Q3 Top 20% -5.4% -26.5%
2022Q1 Top 20% -10.0% -7.2%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
133
Change in large funds
+33
Total value they hold
$6.4B
Funds buying for the first time
79
Funds that sold out entirely
27
Price change that quarter
+8.2%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
5

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-0.85
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
+121.5%
Net margin
-229.9%
ROE
-12.1%
Debt ratio
4.6%
FCF (TTM)
-$144M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.28 2021-12-31: EPS -0.28 2022-03-31: EPS -0.29 2022-06-30: EPS -0.28 2022-09-30: EPS -0.33 2022-12-31: EPS -0.33 2023-03-31: EPS -0.32 2023-06-30: EPS -0.23 2023-09-30: EPS -0.23 2023-12-31: EPS -0.30 2024-03-31: EPS -0.35 2024-06-30: EPS -0.24 2024-09-30: EPS -0.27 2024-12-31: EPS -0.33 2025-03-31: EPS -0.36 2025-06-30: EPS -0.35 2025-09-30: EPS 0.13 2025-12-31: EPS -0.29 2026-03-31: EPS -0.32 2026-06-30: EPS -0.37 0M 27M 54M $M -0.41 -0.13 0.14 202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-44M-22M0K 2020202120222023202420252026
Latest quarter $-44M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.